2023 would be tough with the unchanged macroeconomic condition, plus the looming recession ahead. On the contrary, investors could actually keep their healthy portfolio by having a longer-term view. Don’t worry, here is a round up analysis on potential five stocks from Wall Street analysts. The first one is STAAR Surgical. STAA’s surgical corrections for eye conditions has driven strong demand in the company. Ryan Zimmerman, a BTIG analyst added that demographic trends plus the increased number of myopia cases lead to more demands on STAAR products.
Last December STAAR announced that Thomas Frinzi succeeded Caren Mason. Previously, Frinzi served as head of Johnson & Johnson’s vision unit. Plus he was the president of Abbott Medical Optics. Zimmerman is confident that Frinzi could appease investors. This is because he has 40 years of experience in medical optics. Analysts argued that there would be more demand in STAAR products. For example, next-gen lenses could drive the near-term growth like presbyopia and cataract.
Among more than 8.000 analysts, Zimmerman ranks no. 861 tracked on TipRanks. Furthermore, 44% of the ratings are profitable with each generating around 7.2% average returns. Somehow, another stock like Papa John’s encountered challenges in 2022 due to many reasons. Some of them are the U.K. and inflationary pressures. But it does not always mean that it is not a profitable stock. Papa John is quick-service pizza Papa John’s, the name is PZZA stock. Peter Saled, BTIG analyst said that Papa John’s value offering targets new lower-income customers, especially in the Papa Pairings.